![](/img/cover-not-exists.png)
Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial
Jay R. Lieberman, Nadia Rosencher, Frank MisselwitzVolume:
24
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/j.arth.2008.11.054
File:
PDF, 20 KB
english, 2009